Amicus Therapeutics News

Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(5.1%),Jeremy C. Green(5.1%)

Nov 14 21:06 ET

Amicus Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-William Blair Investment Management, LLC(5.3%)

Nov 14 11:41 ET

Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(7.8%),Behzad Aghazadeh(7.8%)

Nov 14 09:36 ET

Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(8.08%),Wellington Group Holdings LLP(8.08%), etc.

Nov 8 10:55 ET

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L

Nov 7 17:53 ET

Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 6 17:09 ET

Amicus Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:11 ET

Amicus Therapeutics | 8-K: Current report

Nov 6 07:02 ET

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L

Nov 4 18:24 ET

Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 1 16:53 ET

Amicus Therapeutics | 8-K: Current report

Oct 17 07:05 ET

Amicus Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(4.3%)

Oct 7 13:28 ET

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L

Oct 4 16:10 ET

Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Oct 1 16:36 ET

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L

Sep 5 17:03 ET

Amicus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 3 16:22 ET

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Harford Simon N.R.

Aug 23 17:12 ET

Amicus Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 8 16:48 ET

Amicus Therapeutics | 8-K: Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates

Aug 8 07:04 ET

Amicus Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Campbell Bradley L

Aug 5 20:12 ET